Top Tweets for #Addimmune
#Addimmune is participating in the #WalktoEndHIV with @WhitmanWalker in #DC. Join us on October 21st to raise funds to support WWH’s mission of providing dependable, high-quality & accessible #healthcare to those living with or affected by #HIV/#AIDS. https://t.co/GzJYMacaGI
#Addimmune is participating in the #WalktoEndHIV with @WhitmanWalker in #DC. Join us on October 21st to raise funds to support WWH’s mission of providing dependable, high-quality & accessible #healthcare to those living with or affected by #HIV/#AIDS. https://t.co/TpASSxRTQK
Building on encouraging Phase I results, #Addimmune is working towards launching a Phase II trial to establish its #HIV #genetherapy #treatment efficacy. Read on Precision Medicine Online. https://t.co/vBvUjEMPqN
With today’s technology, #genetherapy can be used to correct #pathogenic genes, including #genes from viruses. To combat #HIV, #Addimmune employs AGT103-T to give the #immune system HIV-resistance capabilities. Learn more here. https://t.co/YHtQobqX8R
We’ve entered a merger agreement with @10XCapitalVC! “10X is proud to support #Addimmune in advancing its mission of curing #HIV.” - Hans Thomas, Chairman and CEO of 10X III. Read more here. https://t.co/AnJe9pUlGk
@Addimmune has entered a merger agreement with @10XCapitalVC! “10X is proud to support #Addimmune in advancing its mission of curing #HIV.” - Hans Thomas, Chairman and CEO of 10X III. Read more here. https://t.co/rfJsYqOAzA
@Addimmune has entered a merger agreement with @10XCapitalVC! “10X is proud to support #Addimmune in advancing its mission of curing #HIV.” - Hans Thomas, Chairman and CEO of 10X III. Read more here. https://t.co/702g5UUvba
Happy #Women’sEqualityDay! #Addimmune recognizes the brilliant women who fought for #WomensSuffrage, and those who continue to fight for #genderequality today.
BREAKING: #Addimmune to go public through a #business combination with @10XCapitalVC! Find out more here. https://t.co/STReWugkFA
“That’s why we spun out Addimmune as a separate company in #HIV, because we believe that the data justifies full focus and full funding.” - CEO @JeffreyGalvin on #Addimmune’s mission to advance towards a functional #HIVCure. Read on @GENbio. https://t.co/1tuR6J9SlL
AGT103-T, #Addimmune’s single-infusion autologous #celltherapy, is designed to act as a functional #cure for #HIV – meaning patients would never develop #AIDS, require #antiretroviral therapy, or spread HIV. Read on Precision Medicine Online. https://t.co/SzH8S0PQoW
It was an honor to host @MarilynBalcombe at our #Rockville office! Thank you, Councilmember Balcombe, for all of the amazing work you do for #MontgomeryCounty – #Addimmune looks forward to your continued support as we pursue a cure for #HIV!
Joining YouTube creator and #HIVactivist @raifderrazi, CEO @JeffreyGalvin discusses @Addimmune’s next steps after a successful #HIV Phase 1 clinical trial. Watch here for a look into #Addimmune’s plan to advance research in pursuit of an #HIVcure. https://t.co/3xyuQMVrHh
Joining YouTube creator and #HIVactivist @raifderrazi, CEO @JeffreyGalvin discusses #Addimmune’s next steps after a successful #HIV Phase 1 clinical trial. Watch here for a look into our plan to advance research in pursuit of an #HIVcure. https://t.co/HJIqJQdGw3
In case you missed the party: #Addimmune was launched with the sole purpose of curing HIV! We had the pleasure of hosting elected government officials, #LifeSciences enthusiasts and our passionate supporters who want to see an end to #HIV. Watch here. https://t.co/gFSM0gCqbW
#HIVClinicalTrialUpdate: Phase 1 is complete and #Addimmune is designing protocol for the next phase of the clinical trial. #ATI results showed promising data and significant viral suppression! There’s more work to be done, but the data is encouraging.
#HIVClinicalTrialUpdate: Phase 1 is complete and #Addimmune is designing protocol for Phase 2. #ATI results showed promising data and significant viral suppression! There’s more work to do, but the data is encouraging. Follow @Addimmune for updates. https://t.co/qIcmAmRYso
Interviewed by @raifderrazi: CEO @JeffreyGalvin shares insight on the AGT103-T #HIV Phase 1 clinical trial and #Addimmune’s plans for Phase 2. Watch here. https://t.co/Y3S0tHQZLy
After 15 years of work with @americangene, CEO @JeffreyGalvin shares the reasoning behind the launch of #Addimmune – a spinoff company focused on advancing research towards an #HIVcure. Watch on CityBiz’s #CEOInterviews series. https://t.co/uIiAFTTg47
Happy #InternationalDragDay! The #art of #Drag has played a monumental role in #genderexpression – specifically for the #LGBTQ community. We acknowledge the importance of Drag as both a method of #expression and #activism.
#Addimmune #DragQueen #DragKing
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.3M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109.6M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.4M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.7M followers
KATY PERRY
@katyperry
87.2M followers
Taylor Swift
@taylorswift13
81M followers
Lady Gaga
@ladygaga
72.5M followers
Kim Kardashian
@kimkardashian
69.5M followers
Virat Kohli
@imvkohli
69.1M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.6M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.7M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60.3M followers